In other words, the entry of biosimilars into a reference product's market does not guarantee patient savings. Benefit design ...
A Milwaukee hospital alleges CVS used its control of a PBM, specialty pharmacy and third-party administrator to reduce ...
"Understanding the financial challenges LGBTQ+ adults face when accessing health care can help identify persistent gaps in ...
Nearly 70% of the estimate rests on payments above an insurer-calculated benchmark that a federal appeals court recently ...
This not only would be the fifth-consecutive year of elevated cost growth but also would be the largest annual increase since ...
UnitedHealth Group's UnitedHealthcare unit has posted a list of procedure codes for about 1,700 procedures that will no ...
A new analysis of disclosures from 10 of the largest brand drugmakers, contained from the Centers for Medicare and Medicaid ...
USI is a Valhalla, New York-based company with 10,500 employees, 200 U.S. offices, about $3.3 billion in total annual revenue and about $1.5 billion in U.S. benefits revenue. It appears to be a bit ...
These agreements bring the total number of pharmaceutical manufacturers with MFN deals to 26, covering nearly 90% of the ...
Regulators in are warning would-be insurance producers against trusting recruiters who seem a little too helpful.
The agency alleged that The Villages Health System, based in the 55-plus community of The Villages in central Florida, submitted false diagnosis codes to increase payments from the Medicare Advantage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results